MOLECULAR DIAGNOSTICS(MDX) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-86545 | Service
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Molecular Diagnostics(MDx) Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL MOLECULAR DIAGNOSTICS(MDX) MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL MOLECULAR DIAGNOSTICS(MDX) MARKET
7.1 GLOBAL MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS(MDX) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Siemens Healthineers AG
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Genetic Signatures
16.3 Thermo Fisher Scientific Inc
16.4 Luminex Corporation
16.5 F Hoffmann-La Roche Ltd
16.6 ELITechGroup
16.7 Amoy Diagnostics Co, Ltd
16.8 DiaSorin SpA
16.9 Grifols SA
16.10 Myriad Genetics Inc
16.11 TBG Diagnostics Ltd
16.12 Savyon Diagnostics Ltd
16.13 QIAGEN
16.14 Abbott Laboratories
16.15 GenMark Diagnostics Inc
16.16 HTG Molecular Diagnostics Inc
16.17 Illumina Inc
16.18 Molbio Diagnostics Pvt Ltd
16.19 Becton, Dickinson and Company
16.20 Danaher Corporation
16.21 bioMérieux SA
16.22 Exact Sciences Corporation
16.23 Quidel Corporation
16.24 MDxHealth, Inc
16.25 Biocartis NV
16.26 Agilent Technologies Inc
16.27 ABACUS Diagnostica Oy
16.28 Vela Diagnostics
16.29 geneOmbio Technologies Pvt Ltd
16.30 Hologic, Inc
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredAssays (Services)
Instruments
Reagents & Kits
Major Downstream Industry Covered
Genetic Tests
Others
Infectious Disease Diagnostics
Oncology Testing
Companies
Siemens Healthineers AG
Genetic Signatures
Thermo Fisher Scientific Inc
Luminex Corporation
F Hoffmann-La Roche Ltd
ELITechGroup
Amoy Diagnostics Co, Ltd
DiaSorin SpA
Grifols SA
Myriad Genetics Inc
TBG Diagnostics Ltd
Savyon Diagnostics Ltd
QIAGEN
Abbott Laboratories
GenMark Diagnostics Inc
HTG Molecular Diagnostics Inc
Illumina Inc
Molbio Diagnostics Pvt Ltd
Becton, Dickinson and Company
Danaher Corporation
bioMérieux SA
Exact Sciences Corporation
Quidel Corporation
MDxHealth, Inc
Biocartis NV
Agilent Technologies Inc
ABACUS Diagnostica Oy
Vela Diagnostics
geneOmbio Technologies Pvt Ltd
Hologic, Inc
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.